All breast cancers tested were hormone-receptor-positive (oestrogen receptor average 11.1 ± 2, progesterone receptor average 9.8 ± 3.8) and Her2/neu negative (score 0: 34%, score 1+: 64%, and score 2+ with negative FISH analysis: 2%). This evidence concerns the gene NR4A1 and breast carcinoma.